Equities

Waldencast PLC

WALD:NAQ

Waldencast PLC

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (USD)4.26
  • Today's Change0.14 / 3.40%
  • Shares traded60.00
  • 1 Year change-59.74%
  • Beta-0.5201
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 19-Sep-24
Select bar for recommendation details.
Recommendations19-Sep-24
Buy1
Outperform2
Hold1
Sell0
Strong Sell0

Share price forecast in USD

The 3 analysts offering 12 month price targets for Waldencast PLC have a median target of 6.00, with a high estimate of 7.25 and a low estimate of 4.00. The median estimate represents a 40.85% increase from the last price of 4.26.
High70.2%7.25
Med40.8%6.00
Low-6.1%4.00

Earnings history & estimates in USD

On Aug 27, 2024, Waldencast PLC reported 2nd quarter 2024 losses of -0.05 per share.
The next earnings announcement is expected on Nov 20, 2024.
Average growth rate-716.67%
Waldencast PLC reported annual 2023 losses of -0.99 per share on Apr 30, 2024.
Average growth rate-94.12%
More ▼

Revenue history & estimates in USD

Waldencast PLC had 2nd quarter 2024 revenues of 63.30m. This bettered the 58.30m consensus of the 4 analysts covering the company. The same period last year the company did not report revenues.
Average growth rate-43.03%
Waldencast PLC had revenues for the full year 2023 of 218.14m. This was 31.30% above the prior year's results.
Average growth rate+31.30%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.